Total Payments
$108,579
2024 Payments
$845.88
Companies
57
Transactions
387
Medicare Patients
2,247
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$100,000 (92.1%)
Food & Beverage$8,579 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Charitable Contribution | $100,000 | 1 | 92.1% |
| Food and Beverage | $8,579 | 386 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $100,770 | 24 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $833.80 | 40 | $0 (2023) |
| AbbVie Inc. | $729.41 | 34 | $0 (2021) |
| Amgen Inc. | $432.27 | 19 | $0 (2022) |
| Merck Sharp & Dohme LLC | $429.90 | 21 | $0 (2024) |
| West Therapeutics Development, LLC | $371.45 | 21 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $348.82 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $317.89 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $302.63 | 16 | $0 (2024) |
| PFIZER INC. | $278.27 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $845.88 | 34 | Incyte Corporation ($129.37) |
| 2023 | $902.36 | 39 | E.R. Squibb & Sons, L.L.C. ($157.71) |
| 2022 | $1,017 | 39 | Myriad Genetic Laboratories, Inc. ($192.03) |
| 2021 | $957.26 | 47 | AbbVie Inc. ($202.60) |
| 2020 | $938.01 | 50 | Bayer HealthCare Pharmaceuticals Inc. ($197.24) |
| 2019 | $998.66 | 43 | E.R. Squibb & Sons, L.L.C. ($181.99) |
| 2018 | $1,209 | 62 | Celgene Corporation ($214.05) |
| 2017 | $101,711 | 73 | Celgene Corporation ($100,440) |
All Payment Transactions
387 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Diagnostic Imaging | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug), Stivarga | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $26.95 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $40.35 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: Hematology/Oncology | ||||||
| 07/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: ONCOLOGY | ||||||
| 05/28/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $14.77 | General |
| 05/23/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 05/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $27.18 | General |
| Category: Hematology/Oncology | ||||||
| 04/30/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $23.02 | General |
| Category: Hematology/Oncology | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 44 | 319 | $42,832 | $32,718 |
| 2021 | 28 | 693 | 40,935 | $539,251 | $360,722 |
| 2020 | 39 | 1,510 | 133,540 | $1.8M | $1.2M |
Total Patients
2,247
Total Services
174,794
Medicare Billing
$1.6M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 276 | $35,488 | $27,123 | 76.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 43 | $7,344 | $5,594 | 76.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 15 | 1,700 | $142,800 | $101,272 | 70.9% |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Office | 2021 | 21 | 9,700 | $127,500 | $98,742 | 77.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 491 | $62,400 | $47,372 | 75.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 33 | 200 | $34,163 | $26,841 | 78.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 230 | $20,573 | $15,048 | 73.1% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2021 | 30 | 219 | $17,634 | $13,973 | 79.2% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2021 | 12 | 23 | $17,857 | $11,513 | 64.5% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 34 | 550 | $15,571 | $8,517 | 54.7% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2021 | 14 | 1,241 | $11,169 | $8,299 | 74.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 59 | $9,912 | $7,710 | 77.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 33 | 1,720 | $31,760 | $3,963 | 12.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $4,881 | $3,608 | 73.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 58 | 367 | $4,500 | $2,793 | 62.1% |
| J9263 | Injection, oxaliplatin, 0.5 mg | Office | 2021 | 23 | 21,092 | $21,092 | $1,906 | 9.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 15 | 26 | $2,390 | $1,594 | 66.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 35 | $1,894 | $1,371 | 72.4% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 17 | 44 | $1,672 | $1,288 | 77.0% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 11 | 35 | $1,225 | $980.00 | 80.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 23 | 67 | $2,077 | $852.91 | 41.1% |
| 96360 | Hydration infusion into a vein 31 minutes to 1 hour | Office | 2021 | 12 | 25 | $1,826 | $810.79 | 44.4% |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 2021 | 19 | 246 | $1,992 | $742.90 | 37.3% |
| 96361 | Hydration infusion into a vein | Office | 2021 | 13 | 52 | $988.00 | $659.87 | 66.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 11 | 14 | $516.00 | $402.37 | 78.0% |
About Dr. William Isacoff, M.D
Dr. William Isacoff, M.D is a Hematology & Oncology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891773123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Isacoff, M.D has received a total of $108,579 in payments from pharmaceutical and medical device companies, with $845.88 received in 2024. These payments were reported across 387 transactions from 57 companies. The most common payment nature is "Charitable Contribution" ($100,000).
As a Medicare-enrolled provider, Isacoff has provided services to 2,247 Medicare beneficiaries, totaling 174,794 services with total Medicare billing of $1.6M. Data is available for 3 years (2020–2022), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Santa Monica, CA
- Active Since 01/06/2006
- Last Updated 05/03/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891773123
Products in Payments
- OPDIVO (Biological) $666.98
- CREON (Drug) $374.46
- KEYTRUDA (Biological) $370.04
- Abraxane (Drug) $363.28
- Lazanda (Drug) $358.27
- Creon (Drug) $354.95
- Stivarga (Drug) $304.06
- Lonsurf (Drug) $218.65
- JAKAFI (Drug) $209.27
- TAGRISSO (Drug) $182.99
- Neulasta (Biological) $180.86
- SANCUSO (Drug) $170.98
- GILOTRIF (Drug) $165.60
- Enhertu (Drug) $158.21
- TECENTRIQ (Biological) $153.42
- myRisk (Device) $138.18
- Subsys (Drug) $136.78
- AKYNZEO (Drug) $119.49
- SOMATULINE DEPOT (Drug) $115.19
- Lenvima (Drug) $112.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Santa Monica
Omid Hamid, M.d, M.D
Hematology & Oncology — Payments: $981,950
Hematology & Oncology $981,950
Steven O'day, M.d, M.D
Hematology & Oncology — Payments: $594,773
Hematology & Oncology $594,773
Steven Wong, Md, MD
Hematology & Oncology — Payments: $421,118
Hematology & Oncology $421,118
Silvana Martino, D.o, D.O
Hematology & Oncology — Payments: $179,144
Hematology & Oncology $179,144
Miss. Blanca Ledezma, Msn, Np, MSN, NP
Hematology & Oncology — Payments: $148,836
Hematology & Oncology $148,836
Dr. Arun Singh, M.d, M.D
Hematology & Oncology — Payments: $121,941
Hematology & Oncology $121,941